[8-K] General Enterprise Ventures, Inc. Reports Material Event

Rhea-AI Filing Summary

General Enterprise Ventures, Inc. entered into Securities Purchase Agreements for a PIPE financing. The company agreed to sell 193,967 shares of Series C Convertible Preferred Stock for an aggregate purchase price of $2,909,515, each preferred share convertible into 3.3333 shares of common stock. Investors also received warrants to purchase up to 323,276 common shares, exercisable immediately at an exercise price of $6.00 per share. The combined price was $15.00 per preferred share and accompanying warrant. The securities were sold to accredited investors under Section 4(a)(2) and are not listed for trading.

Univest Securities, LLC served as placement agent, receiving a cash fee of 8% of gross proceeds and placement agent warrants equal to 5% of the total common shares issuable upon conversion and exercise, with an exercise price of $5.40 per share. The company also appointed Lorenzo Calinawan and Craig Huff to its Board, effective October 15, 2025.

Insights

Capital markets analyst

PIPE raises $2,909,515 with convertible preferred and warrants; neutral impact.

The company executed a private investment in public equity, issuing Series C preferred and accompanying warrants. Terms include 193,967 preferred shares convertible at 3.3333 common per preferred and warrants for up to 323,276 common shares exercisable at $6.00. The package price was $15.00 per preferred share plus warrant.

Cash costs include a placement fee of 8% of gross proceeds and additional placement agent warrants equal to 5% of the total common stock issuable upon conversion and warrant exercise, at an exercise price of $5.40. Securities were offered to accredited investors under Section 4(a)(2), and are not intended for exchange listing, so any liquidity depends on conversions and warrant exercises.

Governance changes include two director appointments effective October 15, 2025. Actual dilution and cash inflows from warrant exercises will depend on holder actions and market conditions; timing is not detailed in the excerpt.

0000894556false00008945562025-10-152025-10-15iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 15, 2025

General Enterprise Ventures, Inc.

(Exact name of registrant as specified in its charter)

Wyoming		000-56567		87-2765150
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

1740H Del Range Blvd, Suite 166

Cheyenne, WY 82009

(Address of principal executive offices) (zip code)

800-401-4535

(Registrant’s telephone number, including area code)

________________________________

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On October 21, 2025, General Enterprise Ventures, Inc. (the “Company”) entered into Securities Purchase Agreements (the “Securities Purchase Agreements”) with certain investors (the “Investors”) for the issuance and sale (the “PIPE Offering”) of (i) 193,967 shares of its Series C Convertible Preferred Stock par value $0.0001 per share for an aggregate purchase price of $2,909,515 (the “Series C Preferred Stock”), each convertible into 3.3333 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and (ii) warrants (the “PIPE Warrants”) to purchase up to 323,276 shares of Common Stock at an offering price of $15.00 per share of Series C Preferred Stock and accompanying PIPE Warrant. The PIPE Warrants are exercisable immediately upon issuance at an exercise price of $6.00 per share, subject to customary adjustments for stock splits, reorganizations and such similar events, and will expire five years from the date of issuance. The 193,967 shares of Series C Preferred Stock are referred to herein as the “Preferred Stock Shares”. The Securities Purchase Agreement includes representations, warranties, and covenants customary for a transaction of this type. There is no trading market available for the Preferred Stock Shares or the PIPE Warrants on any securities exchange or nationally recognized trading system. The Company does not intend to list the Preferred Stock Shares or PIPE Warrants on any securities exchange or nationally recognized trading system.

Univest Securities, LLC acted as placement agent (the “Placement Agent”) in connection with the PIPE Offering, pursuant to that certain Placement Agency Agreement, dated as of September 30, 2025, between the Company and the Placement Agent (the “Placement Agency Agreement”). Pursuant to the Placement Agency Agreement, the Company (i) paid the Placement Agent a cash fee equal to 8% of the gross proceeds from the PIPE Offering, and (ii) issued the Placement Agent, or its designees, warrants to purchase up to a number of shares of Common Stock (the “Placement Agent Warrants”) equal to 5% of the total number of Common Stock issuable upon conversion of the Preferred Stock Shares and exercise of the PIPE Warrants sold in the PIPE Offering. The Placement Agent Warrants have substantially the same terms as the PIPE Warrants except that the exercise price per share of Common Stock is equal to 120% of the exercise price of the Common Warrants, or $5.40 per share.

The securities being offered and sold by the Company in the PIPE Offering and the Placement Agent Warrants have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (the “SEC”) or an applicable exemption from such registration requirements. The securities were offered only to accredited investors.

The foregoing descriptions of the Securities Purchase Agreements, PIPE Warrants, Placement Agent Agreement and the Placement Agent Warrant do not purport to be a complete description of such documents and are qualified in their entirety by reference to the full text of each document, copies of which are filed herewith as Exhibits 4.1, 10.1, 10.2 and 10.3, respectively, and incorporated by reference herein.

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth in Item 1.01 of this Current Report on Form 8-K with regard to the offer and sale of the Preferred Stock Shares and the PIPE Warrants to the Investors and the issuance of the Placement Agent Warrants is incorporated herein by reference. The Preferred Stock Shares, the PIPE Warrants, and the Placement Agent Warrants were issued and sold by the Company and the future issuance of Common Stock pursuant to conversions of the Preferred Stock Shares and the exercise of the PIPE Warrants and the Placement Agent Warrants in reliance upon an exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers

Director Appointments

Effective as of October 15, 2025, Lorenzo Calinawan and Craig Huff were appointed as members of the Board of Directors of the Company.

Mr. Huff is the founder and managing member of BoltRock Holdings LLC, a family investment firm and significant shareholder in the Company. Prior to founding BoltRock, Mr. Huff co-founded and served as co-chief executive officer of Reservoir Capital, a multi-billion dollar opportunistic investment firm, for over two decades. He also served in the U.S. Navy as a nuclear engineer and nuclear submarine officer. Mr. Huff has extensive board experience in both private and public companies across a wide range of sectors, including the insurance industry. He holds a bachelor’s degree in engineering physics, magna cum laude, from Abilene Christian University, and an MBA with high distinction from Harvard Business School where he was recognized as a Baker Scholar.

Mr. Calinawan is the co-founder and managing director of Chemlink Partners, a boutique M&A advisory firm focused exclusively on the global chemicals, specialty materials and adjacent industrial sectors. Over his career, Mr. Calinawan has advised on more than $90 billion of completed transactions, including landmark deals, transformative carve-outs, platform builds and cross-border transactions for leading strategics and private equity sponsors. Prior to founding Chemlink, he held senior investment banking roles at Citibank and Piper Sandler and also served as an investment professional at SK Capital Partners, where he focused on building and growing specialty chemicals and materials platforms. Mr. Calinawan brings deep sector knowledge, a global network and proven transaction execution and investment expertise to the company’s board.

There are no arrangements between Mr. Huff or Mr. Calinawan and any other person pursuant to which he was selected to become a director of the Company. Mr. Huff and Mr. Calinawan do not have any family relationships with any executive officer or director of the Company, or with any person selected to become an officer or director of the Company. Neither Mr. Huff, Mr. Calinawan nor any member of his immediate family has any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

2

Item 9.01 Financial Statements and Exhibits

Exhibit No.		Description
4.1		Form of PIPE Warrant
10.1		Form of Securities Purchase Agreement
10.2		Placement Agent Agreement
10.3		Form of Placement Agent Warrant
104		Cover Page Interactive Data File (embedded with the Inline XBRL document)

Forward-Looking Statements

This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding, the formation of the Corporation, the expected benefits from the Corporation, and the investments related to the Corporation. You can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “forecasts,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements use these words or expressions.

We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. The forward-looking statements in this Current Report on Form 8-K are based upon information available to us as of the date of this Current Report on Form 8-K, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	General Enterprise Ventures, Inc.
Date: October 21, 2025	By:	/s/ Wesley J. Bolsen
		Chief Executive Officer

4

FAQ

What financing did GEVI (GEVI) announce in its 8-K?

GEVI entered into Securities Purchase Agreements for a PIPE, selling 193,967 Series C preferred shares for $2,909,515 and issuing warrants for up to 323,276 common shares.

What are the key terms of GEVI’s Series C preferred stock?

Each preferred share is convertible into 3.3333 common shares. The package price was $15.00 per preferred share and accompanying warrant.

What are the PIPE warrant terms for GEVI?

PIPE Warrants are exercisable immediately at an exercise price of $6.00 per share and expire five years from issuance.

Were the GEVI securities registered or listed?

They were issued under Section 4(a)(2) to accredited investors and are not listed on any securities exchange; the company does not intend to list them.

What compensation did the placement agent receive from GEVI?

Univest Securities, LLC received a cash fee of 8% of gross proceeds and warrants equal to 5% of total common shares issuable upon conversion and warrant exercise, with an exercise price of $5.40 per share.

Who joined GEVI’s Board of Directors?

Lorenzo Calinawan and Craig Huff were appointed as directors effective October 15, 2025.